Clonal Hematopoiesis of Indeterminate Potential and Adverse Outcomes

Learning Objectives:

• Define Clonal Hematopoiesis and CH of Indeterminate Potential.
• Outline the Role of CHIP in Inflammation and Ageing.
• Review CHIP and Clonal Evolution of Hematological Malignancies.
• Outline Vascular Outcomes and Future Directions.

Mrinal S. Patnaik, M.B.B.S.
Assistant Professor of Oncology, College of Medicine

Consultant - Division of Hematology, Department of Internal Medicine

Associate Professor of Medicine, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, Minnesota

LOCATION:  Virtual Only, via Zoom

8:00 – 9:00 AM (MST)  | 10:00 – 11:00 AM (CST) |11:00 AM – Noon (EST)

Register in advance for this webinar using the link below:

ABOUT Cancer Center Grand Rounds held weekly on Thursdays for faculty and junior faculty, investigators and junior investigators, scholars, graduate students, medical students, research fellows, administration and allied health staff.

Credit Statement(s) In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medicine Education (ACCME), the Accreditation Council of Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCCP) to provide continuing education for the healthcare team.

AMA The Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ATTENDANCE A unique presentation code must be sent via text to 507-200-3010 to record attendance and to ensure you receive CME credit for your attendance.  NOTE:  Attendees must be present to receive code.